21/01/2015 - 21:38
The U.S. Food and Drug Administration has approved secukinumab for the treatment of moderate to severe plaque psoriasis in adults.
The injectable interleukin-17A inhibitor is indicated for...
Field of Interest: Dermatology
Categories:
News Feed: Internal Medicine News - Dermatology